Pieris napi chromosome 8, ilPieNapi1.2, whole genome shotgun sequence.
Eukaryota; Metazoa; Ecdysozoa; Arthropoda; Hexapoda; Insecta; Pterygota; Neoptera; Endopterygota; Lepidoptera; Glossata; Ditrysia; Papilionoidea; Pieridae; Pierinae; Pieris.
REFSEQ INFORMATION: The reference sequence is identical to\nFR997702.1.\nAssembly name: ilPieNapi1.2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the WELLCOME SANGER INSTITUTE on\n2022/01/30. The original whole-genome shotgun project has the\naccession CAJQFT000000000.2.\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Pieris napi Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 103 samples with support for all annotated introns
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X1
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X2
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X7
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X3
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X5
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X4
DNA polymerase subunit gamma-1, mitochondrial, transcript variant X6
DNA polymerase subunit gamma-1, mitochondrial isoform X6
DNA polymerase subunit gamma-1, mitochondrial isoform X3
DNA polymerase subunit gamma-1, mitochondrial isoform X2
DNA polymerase subunit gamma-1, mitochondrial isoform X1
DNA polymerase subunit gamma-1, mitochondrial isoform X4
DNA polymerase subunit gamma-1, mitochondrial isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
peptidyl-prolyl cis-trans isomerase D-like, transcript variant X2
peptidyl-prolyl cis-trans isomerase D-like, transcript variant X1
peptidyl-prolyl cis-trans isomerase D-like isoform X2
peptidyl-prolyl cis-trans isomerase D-like isoform X1
centrosomal protein of 97 kDa, transcript variant X1
centrosomal protein of 97 kDa, transcript variant X2
centrosomal protein of 97 kDa isoform X2
centrosomal protein of 97 kDa isoform X1
GPI mannosyltransferase 3, transcript variant X3
GPI mannosyltransferase 3, transcript variant X1
GPI mannosyltransferase 3, transcript variant X2
hemicentin-1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
hemicentin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
hemicentin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
hemicentin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
hemicentin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
centromere/kinetochore protein zw10-like, transcript variant X1
centromere/kinetochore protein zw10-like, transcript variant X2
centromere/kinetochore protein zw10-like, transcript variant X3
centromere/kinetochore protein zw10-like isoform X1
uncharacterized protein LOC125051504 isoform X2
uncharacterized protein LOC125051504 isoform X3
uncharacterized LOC125051619, transcript variant X1
uncharacterized LOC125051619, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
uncharacterized LOC125051619, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized protein LOC125051619 isoform X1
uncharacterized protein LOC125051619 isoform X3
uncharacterized protein LOC125051619 isoform X2
E3 ubiquitin-protein ligase SH3RF1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
E3 ubiquitin-protein ligase SH3RF1, transcript variant X1
E3 ubiquitin-protein ligase SH3RF1, transcript variant X4
E3 ubiquitin-protein ligase SH3RF1, transcript variant X2
E3 ubiquitin-protein ligase SH3RF1, transcript variant X8
E3 ubiquitin-protein ligase SH3RF1, transcript variant X5
E3 ubiquitin-protein ligase SH3RF1, transcript variant X6
E3 ubiquitin-protein ligase SH3RF1, transcript variant X3
E3 ubiquitin-protein ligase SH3RF1, transcript variant X7
E3 ubiquitin-protein ligase SH3RF1 isoform X1
E3 ubiquitin-protein ligase SH3RF3 isoform X8
E3 ubiquitin-protein ligase SH3RF1 isoform X5
E3 ubiquitin-protein ligase SH3RF1 isoform X4
E3 ubiquitin-protein ligase SH3RF1 isoform X6
E3 ubiquitin-protein ligase SH3RF1 isoform X3
E3 ubiquitin-protein ligase SH3RF1 isoform X7
E3 ubiquitin-protein ligase SH3RF1 isoform X2
E3 ubiquitin-protein ligase SH3RF3 isoform X9
nuclear pore complex protein Nup58, transcript variant X2
nuclear pore complex protein Nup58, transcript variant X1
nuclear pore complex protein Nup58 isoform X2
nuclear pore complex protein Nup58 isoform X1
brain tumor protein, transcript variant X4
brain tumor protein, transcript variant X7
brain tumor protein, transcript variant X6
brain tumor protein, transcript variant X2
brain tumor protein, transcript variant X3
brain tumor protein, transcript variant X1
brain tumor protein, transcript variant X5
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamic acid (anticodon CUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
electron transfer flavoprotein-ubiquinone oxidoreductase, mitochondrial
malignant T-cell-amplified sequence 1 homolog
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X3
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
ankyrin repeat and LEM domain-containing protein 2 homolog, transcript variant X1
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X1
ankyrin repeat and LEM domain-containing protein 2 homolog isoform X2
uncharacterized LOC125051463, transcript variant X2
uncharacterized LOC125051463, transcript variant X1
uncharacterized LOC125051463, transcript variant X3
uncharacterized protein LOC125051463 isoform X3
uncharacterized protein LOC125051463 isoform X2
uncharacterized protein LOC125051463 isoform X1
transfer RNA arginine (anticodon UCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 1-like, transcript variant X1
CAP-Gly domain-containing linker protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
CAP-Gly domain-containing linker protein 1-like isoform X1
CAP-Gly domain-containing linker protein 1-like isoform X2
histone deacetylase 11, transcript variant X1
histone deacetylase 11, transcript variant X2
xylosyl- and glucuronyltransferase LARGE1-like, transcript variant X1
xylosyl- and glucuronyltransferase LARGE1-like, transcript variant X2
xylosyl- and glucuronyltransferase LARGE1-like
intraflagellar transport protein 57 homolog
myosin light chain kinase, smooth muscle-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
myosin light chain kinase, smooth muscle-like, transcript variant X1
myosin light chain kinase, smooth muscle-like
MIT domain-containing protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
MIT domain-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
MIT domain-containing protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
MIT domain-containing protein 1-like isoform X1
MIT domain-containing protein 1-like isoform X2
DNA-directed RNA polymerase III subunit RPC3, transcript variant X1
DNA-directed RNA polymerase III subunit RPC3 isoform X1
DNA-directed RNA polymerase III subunit RPC3, transcript variant X2
DNA-directed RNA polymerase III subunit RPC3, transcript variant X3
DNA-directed RNA polymerase III subunit RPC3 isoform X2
transfer RNA threonine (anticodon UGU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA arginine (anticodon ACG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00001
cleavage and polyadenylation specificity factor subunit 6, transcript variant X1
cleavage and polyadenylation specificity factor subunit 6, transcript variant X2
cleavage and polyadenylation specificity factor subunit 6 isoform X1
cleavage and polyadenylation specificity factor subunit 6 isoform X2
synaptotagmin-10-like, transcript variant X3
synaptotagmin-10-like, transcript variant X1
synaptotagmin-10-like, transcript variant X2
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glutaredoxin domain-containing cysteine-rich protein CG31559-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
guanylate cyclase soluble subunit beta-1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
transfer RNA isoleucine (anticodon AAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial-like
AT-rich interactive domain-containing protein 2, transcript variant X4
AT-rich interactive domain-containing protein 2, transcript variant X3
AT-rich interactive domain-containing protein 2, transcript variant X7
AT-rich interactive domain-containing protein 2, transcript variant X5
AT-rich interactive domain-containing protein 2, transcript variant X2
AT-rich interactive domain-containing protein 2, transcript variant X8
AT-rich interactive domain-containing protein 2, transcript variant X11
AT-rich interactive domain-containing protein 2, transcript variant X9
AT-rich interactive domain-containing protein 2, transcript variant X10
AT-rich interactive domain-containing protein 2, transcript variant X6
AT-rich interactive domain-containing protein 2, transcript variant X1
AT-rich interactive domain-containing protein 2 isoform X4
AT-rich interactive domain-containing protein 2 isoform X3
AT-rich interactive domain-containing protein 2 isoform X7
AT-rich interactive domain-containing protein 2 isoform X5
AT-rich interactive domain-containing protein 2 isoform X2
AT-rich interactive domain-containing protein 2 isoform X8
AT-rich interactive domain-containing protein 2 isoform X11
AT-rich interactive domain-containing protein 2 isoform X9
AT-rich interactive domain-containing protein 2 isoform X10
AT-rich interactive domain-containing protein 2 isoform X6
AT-rich interactive domain-containing protein 2 isoform X1
AF4/FMR2 family member 1, transcript variant X6
AF4/FMR2 family member 1, transcript variant X3
AF4/FMR2 family member 1, transcript variant X2
AF4/FMR2 family member 1, transcript variant X7
AF4/FMR2 family member 1, transcript variant X4
AF4/FMR2 family member 1, transcript variant X5
AF4/FMR2 family member 1, transcript variant X1
uncharacterized LOC125051628, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 131 samples with support for all annotated introns
uncharacterized LOC125051628, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 130 samples with support for all annotated introns
uncharacterized LOC125051628, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
uncharacterized LOC125051628, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 48 samples with support for all annotated introns
uncharacterized protein LOC125051628 isoform X4
uncharacterized protein LOC125051628 isoform X2
uncharacterized protein LOC125051628 isoform X3
uncharacterized protein LOC125051628 isoform X1
protein king tubby, transcript variant X2
protein king tubby, transcript variant X1
protein tumorous imaginal discs, mitochondrial-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial-like, transcript variant X2
protein tumorous imaginal discs, mitochondrial-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 135 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
protein tumorous imaginal discs, mitochondrial-like, transcript variant X5
protein tumorous imaginal discs, mitochondrial-like isoform X2
protein tumorous imaginal discs, mitochondrial-like isoform X3
protein tumorous imaginal discs, mitochondrial-like isoform X4
protein tumorous imaginal discs, mitochondrial-like isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
U8-agatoxin-Ao1a-like, transcript variant X4
U8-agatoxin-Ao1a-like, transcript variant X3
U8-agatoxin-Ao1a-like, transcript variant X1
U8-agatoxin-Ao1a-like, transcript variant X2
uncharacterized protein LOC125051725 isoform X1
uncharacterized protein LOC125051725 isoform X2
transfer RNA aspartic acid (anticodon GUC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125051557, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
uncharacterized LOC125051557, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 161 samples with support for all annotated introns
uncharacterized protein LOC125051557 isoform X1
uncharacterized protein LOC125051557 isoform X2
telomere length and silencing protein 1 homolog
malate synthase-like, transcript variant X1
malate synthase-like, transcript variant X2
probable pyruvate dehydrogenase E1 component subunit alpha, mitochondrial
multidrug resistance protein homolog 49-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
multidrug resistance protein homolog 49-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
multidrug resistance protein homolog 49-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
multidrug resistance protein homolog 49-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
multidrug resistance protein homolog 49-like isoform X3
multidrug resistance protein homolog 49-like isoform X2
multidrug resistance protein homolog 49-like isoform X1
multidrug resistance protein homolog 49-like isoform X4
DNA topoisomerase 3-beta-1, transcript variant X1
DNA topoisomerase 3-beta-1, transcript variant X2
transfer RNA asparagine (anticodon GUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
alpha-N-acetylgalactosaminidase, transcript variant X1
alpha-N-acetylgalactosaminidase, transcript variant X2
alpha-N-acetylgalactosaminidase isoform X1
alpha-N-acetylgalactosaminidase isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
probable cytochrome P450 6a13, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
probable cytochrome P450 6a23 isoform X1
probable cytochrome P450 6a13, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
probable cytochrome P450 6a13 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 84 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
uncharacterized LOC125051541, transcript variant X3
uncharacterized LOC125051541, transcript variant X2
uncharacterized LOC125051541, transcript variant X1
WD repeat domain phosphoinositide-interacting protein 4-like, transcript variant X1
WD repeat domain phosphoinositide-interacting protein 4-like isoform X1
WD repeat domain phosphoinositide-interacting protein 4-like, transcript variant X2
WD repeat domain phosphoinositide-interacting protein 4-like isoform X2
small integral membrane protein 20, transcript variant X1
small integral membrane protein 20, transcript variant X2
probable cytochrome P450 301a1, mitochondrial
probable cytochrome P450 49a1, transcript variant X1
probable cytochrome P450 49a1, transcript variant X3
probable cytochrome P450 49a1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
Hermansky-Pudlak syndrome 5 protein homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 136 samples with support for all annotated introns
transcription factor Sox-5, transcript variant X2
transcription factor Sox-5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X1
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X7
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X3
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X4
ankyrin repeat and SAM domain-containing protein 1A-like isoform X8
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X5
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X2
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X1
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like isoform X6
ankyrin repeat and sterile alpha motif domain-containing protein 1B-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized protein LOC125051860 isoform X7
transfer RNA serine (anticodon AGA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transmembrane 7 superfamily member 3-like, transcript variant X1
transmembrane 7 superfamily member 3-like, transcript variant X2
transmembrane 7 superfamily member 3-like isoform X1
transmembrane 7 superfamily member 3-like isoform X2
paired box protein Pax-6, transcript variant X4
paired box protein Pax-6, transcript variant X2
paired box protein Pax-6, transcript variant X3
paired box protein Pax-6, transcript variant X1
torso-like protein, transcript variant X4
torso-like protein, transcript variant X1
torso-like protein, transcript variant X2
torso-like protein, transcript variant X3
transfer RNA leucine (anticodon CAA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
putative leucine-rich repeat-containing protein DDB_G0290503
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
paired box protein Pax-6-like, transcript variant X1
paired box protein Pax-6-like, transcript variant X2
paired box protein Pax-6-like, transcript variant X3
putative mediator of RNA polymerase II transcription subunit 26
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
paired box protein Pax-6-like isoform X1
paired box protein Pax-6-like isoform X2
paired box protein Pax-6-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 125 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 111 samples with support for all annotated introns
protein goliath-like, transcript variant X1
protein goliath-like, transcript variant X3
protein goliath-like, transcript variant X2
protein goliath-like, transcript variant X4
histone acetyltransferase KAT2A, transcript variant X3
histone acetyltransferase KAT2A, transcript variant X2
histone acetyltransferase KAT2A, transcript variant X1
histone acetyltransferase KAT2A isoform X3
histone acetyltransferase KAT2A isoform X2
histone acetyltransferase KAT2A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
REPTOR-binding partner, transcript variant X1
REPTOR-binding partner, transcript variant X2
uncharacterized LOC125051823, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized protein LOC125051823 isoform X1
uncharacterized LOC125051823, transcript variant X2
uncharacterized protein LOC125051823 isoform X2
small glutamine-rich tetratricopeptide repeat-containing protein alpha-like
EH domain-containing protein 1, transcript variant X1
EH domain-containing protein 1, transcript variant X2
EH domain-containing protein 1 isoform X2
EH domain-containing protein 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 148 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 89 samples with support for all annotated introns
adenosine 3'-phospho 5'-phosphosulfate transporter 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 128 samples with support for all annotated introns
uncharacterized LOC125051479, transcript variant X1
uncharacterized protein LOC125051479 isoform X1
uncharacterized LOC125051479, transcript variant X2
uncharacterized protein LOC125051479 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
hematopoietically-expressed homeobox protein hhex
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125051477, transcript variant X2
uncharacterized LOC125051477, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
uncharacterized LOC125051474, transcript variant X3
uncharacterized LOC125051474, transcript variant X2
uncharacterized LOC125051474, transcript variant X1
uncharacterized LOC125051474, transcript variant X4
uncharacterized LOC125051474, transcript variant X5
uncharacterized protein LOC125051474 isoform X2
uncharacterized protein LOC125051474 isoform X1
uncharacterized protein LOC125051474 isoform X3
cell division protein ZipA, transcript variant X1
cell division protein ZipA, transcript variant X2
uncharacterized abhydrolase domain-containing protein DDB_G0269086-like, transcript variant X1
uncharacterized abhydrolase domain-containing protein DDB_G0269086-like isoform X1
uncharacterized abhydrolase domain-containing protein DDB_G0269086-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized abhydrolase domain-containing protein DDB_G0269086-like isoform X2
protein unc-79 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
protein unc-79 homolog, transcript variant X5
protein unc-79 homolog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
protein unc-79 homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
protein unc-79 homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein unc-79 homolog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transient receptor potential channel pyrexia
LIM domain only protein 7, transcript variant X4
LIM domain only protein 7, transcript variant X1
LIM domain only protein 7, transcript variant X9
LIM domain only protein 7, transcript variant X8
LIM domain only protein 7, transcript variant X7
LIM domain only protein 7, transcript variant X6
LIM domain only protein 7, transcript variant X5
LIM domain only protein 7, transcript variant X2
LIM domain only protein 7, transcript variant X3
uncharacterized protein LOC125051879 isoform X1
transient receptor potential channel pyrexia-like
uncharacterized LOC125051749, transcript variant X1
uncharacterized LOC125051749, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X3
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X5
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X7
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X1
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X2
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X4
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X6
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X10
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X8
phosphatidylinositol-binding clathrin assembly protein LAP, transcript variant X9
phosphatidylinositol-binding clathrin assembly protein LAP isoform X1
phosphatidylinositol-binding clathrin assembly protein LAP isoform X3
phosphatidylinositol-binding clathrin assembly protein LAP isoform X5
phosphatidylinositol-binding clathrin assembly protein LAP isoform X8
phosphatidylinositol-binding clathrin assembly protein LAP isoform X10
phosphatidylinositol-binding clathrin assembly protein LAP isoform X4
phosphatidylinositol-binding clathrin assembly protein LAP isoform X9
phosphatidylinositol-binding clathrin assembly protein LAP isoform X2
phosphatidylinositol-binding clathrin assembly protein LAP isoform X6
phosphatidylinositol-binding clathrin assembly protein LAP isoform X7
acyl-CoA synthetase short-chain family member 3, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
myosuppressin-like, transcript variant X2
myosuppressin-like, transcript variant X1
C2 domain-containing protein 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 111 samples with support for all annotated introns
C2 domain-containing protein 5, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
C2 domain-containing protein 5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
C2 domain-containing protein 5 isoform X3
C2 domain-containing protein 5 isoform X2
C2 domain-containing protein 5 isoform X1
uncharacterized LOC125052073, transcript variant X1
uncharacterized LOC125052073, transcript variant X2
uncharacterized LOC125052073, transcript variant X3
uncharacterized LOC125052073, transcript variant X4
putative peptidyl-prolyl cis-trans isomerase dodo, transcript variant X1
COMM domain-containing protein 4-like isoform X1
putative peptidyl-prolyl cis-trans isomerase dodo, transcript variant X2
putative peptidyl-prolyl cis-trans isomerase dodo isoform X2
stress response protein NST1, transcript variant X3
stress response protein NST1, transcript variant X5
stress response protein NST1, transcript variant X4
stress response protein NST1, transcript variant X7
stress response protein NST1, transcript variant X2
stress response protein NST1, transcript variant X6
stress response protein NST1, transcript variant X1
MAP7 domain-containing protein 2 isoform X3
uncharacterized LOC125051758, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
uncharacterized LOC125051758, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 73 samples with support for all annotated introns
uncharacterized protein LOC125051758 isoform X1
uncharacterized protein LOC125051758 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
general odorant-binding protein 56a-like, transcript variant X1
general odorant-binding protein 56a-like, transcript variant X2
general odorant-binding protein 56a-like isoform X1
general odorant-binding protein 56a-like isoform X2
protein tipE-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
protein tipE-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
protein tipE-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 95 samples with support for all annotated introns
uncharacterized protein LOC125051861 isoform X1
protein tipE-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
uncharacterized LOC125051672, transcript variant X1
uncharacterized LOC125051672, transcript variant X2
uncharacterized protein LOC125051672 isoform X1
uncharacterized protein LOC125051672 isoform X2
flocculation protein FLO11-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
flocculation protein FLO11-like, transcript variant X1
flocculation protein FLO11-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
flocculation protein FLO11-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
flocculation protein FLO11-like, transcript variant X2
transfer RNA tyrosine (anticodon GUA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 32% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized oxidoreductase TM_0325-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 25% coverage of the annotated genomic feature by RNAseq alignments
3-oxoacyl-[acyl-carrier-protein] reductase FabG-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 23% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
transcription initiation factor TFIID subunit 3, transcript variant X2
transcription initiation factor TFIID subunit 3, transcript variant X1
transcription initiation factor TFIID subunit 3, transcript variant X3
transcription initiation factor TFIID subunit 3 isoform X2
transcription initiation factor TFIID subunit 3 isoform X1
transcription initiation factor TFIID subunit 3 isoform X3
general transcription factor IIH subunit 1, transcript variant X1
general transcription factor IIH subunit 1, transcript variant X2
general transcription factor IIH subunit 1
fibroblast growth factor receptor homolog 1-like, transcript variant X2
fibroblast growth factor receptor homolog 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
fibroblast growth factor receptor homolog 1-like isoform X2
fibroblast growth factor receptor homolog 1-like isoform X1
biogenesis of lysosome-related organelles complex 1 subunit 2
putative glutathione-specific gamma-glutamylcyclotransferase 2
CCR4-NOT transcription complex subunit 9, transcript variant X1
CCR4-NOT transcription complex subunit 9, transcript variant X2
CCR4-NOT transcription complex subunit 9
HEAT repeat-containing protein 5B, transcript variant X1
HEAT repeat-containing protein 5B, transcript variant X2
HEAT repeat-containing protein 5B isoform X1
HEAT repeat-containing protein 5B isoform X2
tRNA (adenine(58)-N(1))-methyltransferase catalytic subunit TRMT61A
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
mediator of RNA polymerase II transcription subunit 24
neuronal PAS domain-containing protein 4B-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
neuronal PAS domain-containing protein 4B-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
neuronal PAS domain-containing protein 4B-like isoform X2
neuronal PAS domain-containing protein 4B-like isoform X1
synaptobrevin-1-like, transcript variant X1
synaptobrevin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
neuronal PAS domain-containing protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
vesicle-associated membrane protein 2-like, transcript variant X1
vesicle-associated membrane protein 2-like, transcript variant X2
vesicle-associated membrane protein 2-like isoform X2
vesicle-associated membrane protein 2-like isoform X1
activating signal cointegrator 1 complex subunit 3
nuclear RNA export factor 2-like, transcript variant X2
nuclear RNA export factor 2-like, transcript variant X1
nuclear RNA export factor 2-like isoform X1
nuclear RNA export factor 1-like isoform X2
transcription initiation factor TFIID subunit 12, transcript variant X1
transcription initiation factor TFIID subunit 12, transcript variant X2
transcription initiation factor TFIID subunit 12
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
short coiled-coil protein homolog, transcript variant X2
short coiled-coil protein homolog, transcript variant X1
39S ribosomal protein L19, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
uncharacterized LOC125051695, transcript variant X1
uncharacterized LOC125051695, transcript variant X4
uncharacterized LOC125051695, transcript variant X3
uncharacterized LOC125051695, transcript variant X2
serine-arginine protein 55, transcript variant X6
serine-arginine protein 55, transcript variant X7
serine-arginine protein 55, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 122 samples with support for all annotated introns
serine-arginine protein 55, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 155 samples with support for all annotated introns
serine-arginine protein 55, transcript variant X9
serine-arginine protein 55, transcript variant X8
serine-arginine protein 55, transcript variant X1
serine-arginine protein 55, transcript variant X4
serine-arginine protein 55, transcript variant X2
serine-arginine protein 55, transcript variant X5
serine-arginine protein 55, transcript variant X3
circadian clock-controlled protein daywake-like
chromatin-remodeling ATPase INO80, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 90 samples with support for all annotated introns
chromatin-remodeling ATPase INO80, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 132 samples with support for all annotated introns
zinc finger MYM-type protein 4, transcript variant X1
zinc finger MYM-type protein 4, transcript variant X6
zinc finger MYM-type protein 4, transcript variant X7
zinc finger MYM-type protein 4, transcript variant X3
zinc finger MYM-type protein 4, transcript variant X2
zinc finger MYM-type protein 4, transcript variant X4
zinc finger MYM-type protein 4, transcript variant X5
zinc finger MYM-type protein 3 isoform X1
zinc finger MYM-type protein 4 isoform X2
zinc finger MYM-type protein 3 isoform X3
uncharacterized LOC125051905, transcript variant X2
uncharacterized LOC125051905, transcript variant X1
tubulin monoglutamylase TTLL4-like, transcript variant X1
tubulin monoglutamylase TTLL4-like, transcript variant X5
tubulin monoglutamylase TTLL4-like, transcript variant X2
tubulin monoglutamylase TTLL4-like, transcript variant X8
tubulin monoglutamylase TTLL4-like, transcript variant X4
tubulin monoglutamylase TTLL4-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
tubulin monoglutamylase TTLL4-like, transcript variant X6
tubulin monoglutamylase TTLL4-like, transcript variant X3
uncharacterized protein LOC125051515 isoform X1
tubulin monoglutamylase TTLL4-like isoform X3
tubulin monoglutamylase TTLL4-like isoform X5
uncharacterized protein LOC125051515 isoform X2
tubulin monoglutamylase TTLL4-like isoform X8
tubulin monoglutamylase TTLL4-like isoform X4
tubulin monoglutamylase TTLL4-like isoform X7
tubulin monoglutamylase TTLL4-like isoform X6
transfer RNA alanine (anticodon UGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
protein trachealess, transcript variant X2
protein trachealess, transcript variant X1
uncharacterized LOC125051927, transcript variant X2
uncharacterized LOC125051927, transcript variant X1
rho guanine nucleotide exchange factor 17, transcript variant X5
rho guanine nucleotide exchange factor 17, transcript variant X1
rho guanine nucleotide exchange factor 17, transcript variant X2
rho guanine nucleotide exchange factor 17, transcript variant X3
rho guanine nucleotide exchange factor 17, transcript variant X4
rho guanine nucleotide exchange factor 17 isoform X1
rho guanine nucleotide exchange factor 17 isoform X2
rho guanine nucleotide exchange factor 17 isoform X4
rho guanine nucleotide exchange factor 17 isoform X3
rho guanine nucleotide exchange factor 17 isoform X5
rho GTPase-activating protein 7, transcript variant X1
rho GTPase-activating protein 7, transcript variant X2
rho GTPase-activating protein 7 isoform X1
rho GTPase-activating protein 7 isoform X2
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
rho GTPase-activating protein 7, transcript variant X3
stAR-related lipid transfer protein 13 isoform X3
rho GTPase-activating protein 7, transcript variant X4
rho GTPase-activating protein 7, transcript variant X5
rho GTPase-activating protein 7 isoform X4
rho GTPase-activating protein 7 isoform X5
rho GTPase-activating protein 7, transcript variant X6
rho GTPase-activating protein 7 isoform X6
uncharacterized LOC125051588, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
uncharacterized LOC125051588, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 156 samples with support for all annotated introns
uncharacterized protein LOC125051588 isoform X2
uncharacterized protein LOC125051588 isoform X1
S-adenosylmethionine sensor upstream of mTORC1
E3 ubiquitin-protein ligase KCMF1, transcript variant X2
E3 ubiquitin-protein ligase KCMF1, transcript variant X3
E3 ubiquitin-protein ligase KCMF1, transcript variant X1
E3 ubiquitin-protein ligase KCMF1 isoform X2
E3 ubiquitin-protein ligase KCMF1 isoform X1
E3 ubiquitin-protein ligase Kcmf1 isoform X3
coiled-coil domain-containing protein 115
glycoprotein 3-alpha-L-fucosyltransferase A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
glycoprotein 3-alpha-L-fucosyltransferase A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
glycoprotein 3-alpha-L-fucosyltransferase A
proteasome assembly chaperone 2, transcript variant X1
proteasome assembly chaperone 2, transcript variant X2
proteasome assembly chaperone 2, transcript variant X3
uncharacterized LOC125052033, transcript variant X1
uncharacterized LOC125052033, transcript variant X2
uncharacterized protein LOC125052033 isoform X1
uncharacterized protein LOC125052033 isoform X2
coiled-coil domain-containing protein 174
deoxyuridine 5'-triphosphate nucleotidohydrolase
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X1
myb/SANT-like DNA-binding domain-containing protein 3, transcript variant X2
myb/SANT-like DNA-binding domain-containing protein 3
histone-lysine N-methyltransferase trithorax
ras association domain-containing protein 8, transcript variant X1
ras association domain-containing protein 8, transcript variant X2
ras association domain-containing protein 8 isoform X1
ras association domain-containing protein 8 isoform X2
microtubule-associated protein Jupiter, transcript variant X4
microtubule-associated protein Jupiter, transcript variant X1
microtubule-associated protein Jupiter, transcript variant X2
microtubule-associated protein Jupiter isoform X4
microtubule-associated protein Jupiter isoform X1
microtubule-associated protein Jupiter isoform X2
microtubule-associated protein Jupiter, transcript variant X3
microtubule-associated protein Jupiter isoform X3
cation channel sperm-associated protein 1-like, transcript variant X3
cation channel sperm-associated protein 1-like, transcript variant X2
cation channel sperm-associated protein 1-like, transcript variant X1
uncharacterized protein LOC125051936 isoform X3
cation channel sperm-associated protein 1-like isoform X2
cation channel sperm-associated protein 1-like isoform X1
protein regulator of cytokinesis 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
protein regulator of cytokinesis 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 78 samples with support for all annotated introns
protein regulator of cytokinesis 1-like isoform X1
protein regulator of cytokinesis 1-like isoform X2
cilia- and flagella-associated protein 61-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125052065, transcript variant X3
uncharacterized LOC125052065, transcript variant X2
uncharacterized LOC125052065, transcript variant X1
uncharacterized protein LOC125052065 isoform X2
uncharacterized protein LOC125052065 isoform X1
CLIP domain-containing serine protease 14D-like
gamma-interferon-inducible lysosomal thiol reductase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA proline (anticodon AGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized histidine-rich protein DDB_G0274557, transcript variant X2
uncharacterized protein LOC125051916 isoform X2
uncharacterized histidine-rich protein DDB_G0274557, transcript variant X1
uncharacterized histidine-rich protein DDB_G0274557 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 36 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
general odorant-binding protein 28a-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
general odorant-binding protein 72-like, transcript variant X3
general odorant-binding protein 72-like, transcript variant X2
general odorant-binding protein 72-like isoform X2
general odorant-binding protein 72-like, transcript variant X1
general odorant-binding protein 72-like isoform X1
general odorant-binding protein 72-like isoform X3
nonsense-mediated mRNA decay factor SMG9-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 160 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins
NPC intracellular cholesterol transporter 1 homolog 1b-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
gamma-tubulin complex component 6, transcript variant X2
gamma-tubulin complex component 6, transcript variant X1
39S ribosomal protein L17, mitochondrial
YLP motif-containing protein 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 59 samples with support for all annotated introns
YLP motif-containing protein 1-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
YLP motif-containing protein 1-like, transcript variant X6
YLP motif-containing protein 1-like, transcript variant X1
YLP motif-containing protein 1-like, transcript variant X2
YLP motif-containing protein 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 166 samples with support for all annotated introns
YLP motif-containing protein 1-like isoform X1
YLP motif-containing protein 1-like isoform X2
uncharacterized protein LOC125051733 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC125051735, transcript variant X2
uncharacterized LOC125051735, transcript variant X1
uncharacterized protein LOC125051735 isoform X2
uncharacterized protein LOC125051735 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 87% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
COORDINATES: nucleotide motif:Rfam:12.0:RF00003
CLK4-associating serine/arginine rich protein, transcript variant X4
CLK4-associating serine/arginine rich protein, transcript variant X1
CLK4-associating serine/arginine rich protein, transcript variant X3
CLK4-associating serine/arginine rich protein, transcript variant X2
CLK4-associating serine/arginine rich protein isoform X3
CLK4-associating serine/arginine rich protein isoform X4
CLK4-associating serine/arginine rich protein isoform X2
CLK4-associating serine/arginine rich protein isoform X1
uncharacterized LOC125051574, transcript variant X2
uncharacterized LOC125051574, transcript variant X1
uncharacterized protein LOC125051574 isoform X2
uncharacterized protein LOC125051574 isoform X1
inositol-tetrakisphosphate 1-kinase-like
apoptosis-stimulating of p53 protein 2, transcript variant X5
apoptosis-stimulating of p53 protein 1 isoform X4
apoptosis-stimulating of p53 protein 2, transcript variant X6
apoptosis-stimulating of p53 protein 1 isoform X5
apoptosis-stimulating of p53 protein 2, transcript variant X3
apoptosis-stimulating of p53 protein 2, transcript variant X4
apoptosis-stimulating of p53 protein 1 isoform X3
apoptosis-stimulating of p53 protein 2, transcript variant X1
apoptosis-stimulating of p53 protein 2, transcript variant X2
apoptosis-stimulating of p53 protein 1 isoform X1
apoptosis-stimulating of p53 protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA methionine (anticodon CAU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA alanine (anticodon CGC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125051612, transcript variant X1
uncharacterized LOC125051612, transcript variant X2
uncharacterized protein LOC125051612 isoform X1
uncharacterized protein LOC125051612 isoform X2
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
uncharacterized LOC125051976, transcript variant X2
uncharacterized LOC125051976, transcript variant X1
uncharacterized LOC125051706, transcript variant X1
uncharacterized LOC125051706, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
N-alpha-acetyltransferase 38-B, NatC auxiliary subunit
cytochrome c oxidase assembly factor 6 homolog, transcript variant X1
cytochrome c oxidase assembly factor 6 homolog, transcript variant X2
uncharacterized protein LOC125051482 isoform X1
cytochrome c oxidase assembly factor 6 homolog, transcript variant X3
cytochrome c oxidase assembly factor 6 homolog isoform X2
5,10-methylenetetrahydrofolate reductase
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
NEDD8-activating enzyme E1 regulatory subunit
transmembrane protein 185B, transcript variant X2
transmembrane protein 185B, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
transcription initiation factor TFIID subunit 8
uncharacterized LOC125051713, transcript variant X1
uncharacterized LOC125051713, transcript variant X2
mitochondrial tRNA-specific 2-thiouridylase 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
synaptobrevin homolog YKT6, transcript variant X1
synaptobrevin homolog YKT6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 74 samples with support for all annotated introns
uncharacterized LOC125051575, transcript variant X1
uncharacterized LOC125051575, transcript variant X2
probable methylmalonate-semialdehyde dehydrogenase [acylating], mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
nuclear factor related to kappa-B-binding protein-like, transcript variant X2
nuclear factor related to kappa-B-binding protein-like, transcript variant X4
nuclear factor related to kappa-B-binding protein-like, transcript variant X5
nuclear factor related to kappa-B-binding protein-like, transcript variant X3
nuclear factor related to kappa-B-binding protein-like, transcript variant X1
nuclear factor related to kappa-B-binding protein-like isoform X5
nuclear factor related to kappa-B-binding protein-like isoform X3
nuclear factor related to kappa-B-binding protein-like isoform X2
nuclear factor related to kappa-B-binding protein-like isoform X4
nuclear factor related to kappa-B-binding protein-like isoform X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X2
serine/threonine-protein phosphatase PP1-beta catalytic subunit, transcript variant X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X1
serine/threonine-protein phosphatase PP1-beta catalytic subunit isoform X2
uncharacterized LOC125051521, transcript variant X6
uncharacterized LOC125051521, transcript variant X5
uncharacterized LOC125051521, transcript variant X4
uncharacterized LOC125051521, transcript variant X2
uncharacterized LOC125051521, transcript variant X1
uncharacterized LOC125051521, transcript variant X3
uncharacterized protein LOC125051521 isoform X4
uncharacterized protein LOC125051521 isoform X2
uncharacterized protein LOC125051521 isoform X3
uncharacterized protein LOC125051521 isoform X1
uncharacterized LOC125051521, transcript variant X7
uncharacterized LOC125051521, transcript variant X8
uncharacterized protein LOC125051521 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
transfer RNA arginine (anticodon CCU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
glycogen synthase kinase-3 beta-like, transcript variant X1
glycogen synthase kinase-3 beta-like, transcript variant X3
glycogen synthase kinase-3 beta-like, transcript variant X2
glycogen synthase kinase-3 beta-like, transcript variant X5
glycogen synthase kinase-3 beta-like, transcript variant X4
glycogen synthase kinase-3 beta-like isoform X5
glycogen synthase kinase-3 beta-like isoform X3
glycogen synthase kinase-3 beta-like isoform X2
glycogen synthase kinase-3 beta-like isoform X1
glycogen synthase kinase-3 beta-like isoform X4
leucine-rich repeat-containing protein 58
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 133 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 93% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
uncharacterized protein DDB_G0283357-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
mitochondrial ribonuclease P catalytic subunit, transcript variant X2
mitochondrial ribonuclease P catalytic subunit, transcript variant X1
mitochondrial ribonuclease P catalytic subunit, transcript variant X3
mitochondrial ribonuclease P catalytic subunit isoform X2
mitochondrial ribonuclease P catalytic subunit isoform X1
mitochondrial ribonuclease P catalytic subunit isoform X3
uncharacterized LOC125051751, transcript variant X1
uncharacterized LOC125051751, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC125051751, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
uncharacterized LOC125051751, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 68 samples with support for all annotated introns
uncharacterized LOC125051751, transcript variant X5
uncharacterized protein LOC125051751 isoform X1
uncharacterized protein LOC125051751 isoform X3
uncharacterized protein LOC125051751 isoform X2
REST corepressor 1, transcript variant X2
REST corepressor 1, transcript variant X1
REST corepressor 1, transcript variant X4
REST corepressor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
multiple coagulation factor deficiency protein 2 homolog, transcript variant X1
multiple coagulation factor deficiency protein 2 homolog isoform X1
multiple coagulation factor deficiency protein 2 homolog, transcript variant X2
multiple coagulation factor deficiency protein 2 homolog isoform X2
uncharacterized LOC125051955, transcript variant X1
uncharacterized LOC125051955, transcript variant X2
uncharacterized protein LOC125051955 isoform X2
uncharacterized protein LOC125051955 isoform X1
uncharacterized LOC125051810, transcript variant X3
uncharacterized LOC125051810, transcript variant X1
uncharacterized LOC125051810, transcript variant X2
upstream stimulatory factor 2, transcript variant X1
upstream stimulatory factor 2, transcript variant X2
upstream stimulatory factor 2 isoform X1
upstream stimulatory factor 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 169 samples with support for all annotated introns
uncharacterized LOC125051806, transcript variant X1
uncharacterized LOC125051806, transcript variant X2
uncharacterized protein LOC125051806 isoform X1
uncharacterized protein LOC125051806 isoform X2
putative ATP-dependent RNA helicase DHX57, transcript variant X1
putative ATP-dependent RNA helicase DHX57, transcript variant X2
putative ATP-dependent RNA helicase DHX57 isoform X1
putative ATP-dependent RNA helicase DHX57 isoform X2
inositol-trisphosphate 3-kinase B, transcript variant X4
inositol-trisphosphate 3-kinase B, transcript variant X3
inositol-trisphosphate 3-kinase B, transcript variant X2
inositol-trisphosphate 3-kinase B, transcript variant X1
inositol-trisphosphate 3-kinase B isoform X2
inositol-trisphosphate 3-kinase A isoform X1
serine/threonine-protein kinase minibrain, transcript variant X1
serine/threonine-protein kinase minibrain, transcript variant X2
serine/threonine-protein kinase minibrain, transcript variant X4
serine/threonine-protein kinase minibrain, transcript variant X6
serine/threonine-protein kinase minibrain, transcript variant X9
serine/threonine-protein kinase minibrain, transcript variant X7
serine/threonine-protein kinase minibrain, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
serine/threonine-protein kinase minibrain, transcript variant X8
serine/threonine-protein kinase minibrain isoform X1
serine/threonine-protein kinase minibrain isoform X2
serine/threonine-protein kinase minibrain isoform X4
serine/threonine-protein kinase minibrain isoform X6
serine/threonine-protein kinase minibrain isoform X8
serine/threonine-protein kinase minibrain isoform X7
serine/threonine-protein kinase minibrain, transcript variant X3
serine/threonine-protein kinase minibrain, transcript variant X5
serine/threonine-protein kinase minibrain isoform X3
serine/threonine-protein kinase minibrain isoform X5
serine/threonine-protein kinase minibrain, transcript variant X11
serine/threonine-protein kinase minibrain isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein CG43867, transcript variant X1
uncharacterized protein CG43867, transcript variant X4
uncharacterized protein CG43867, transcript variant X3
uncharacterized protein CG43867, transcript variant X6
uncharacterized protein CG43867, transcript variant X2
uncharacterized protein CG43867, transcript variant X15
uncharacterized protein CG43867, transcript variant X14
uncharacterized protein CG43867, transcript variant X5
uncharacterized protein CG43867 isoform X1
uncharacterized protein CG43867 isoform X4
uncharacterized protein CG43867 isoform X3
uncharacterized protein CG43867 isoform X6
uncharacterized protein CG43867 isoform X2
uncharacterized protein CG43867 isoform X11
uncharacterized protein CG43867 isoform X10
uncharacterized protein CG43867 isoform X5
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
uncharacterized protein CG43867, transcript variant X7
uncharacterized protein CG43867, transcript variant X8
uncharacterized protein CG43867 isoform X7
uncharacterized protein CG43867, transcript variant X12
uncharacterized protein CG43867, transcript variant X10
uncharacterized protein CG43867, transcript variant X9
uncharacterized protein CG43867, transcript variant X11
uncharacterized protein CG43867 isoform X8
uncharacterized protein CG43867, transcript variant X13
uncharacterized protein CG43867 isoform X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 158 samples with support for all annotated introns
pyruvate carboxylase, mitochondrial, transcript variant X2
pyruvate carboxylase, mitochondrial, transcript variant X4
pyruvate carboxylase, mitochondrial, transcript variant X1
pyruvate carboxylase, mitochondrial, transcript variant X3
pyruvate carboxylase, mitochondrial isoform X3
pyruvate carboxylase, mitochondrial isoform X1
pyruvate carboxylase, mitochondrial isoform X2
zinc finger protein OZF-like, transcript variant X1
zinc finger protein OZF-like, transcript variant X3
zinc finger protein OZF-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like isoform X1
pancreatic triacylglycerol lipase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
pancreatic triacylglycerol lipase-like isoform X2
uncharacterized LOC125051657, transcript variant X2
uncharacterized LOC125051657, transcript variant X1
uncharacterized LOC125051658, transcript variant X1
uncharacterized LOC125051658, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
disheveled-associated activator of morphogenesis 1, transcript variant X4
disheveled-associated activator of morphogenesis 1, transcript variant X2
disheveled-associated activator of morphogenesis 1, transcript variant X1
disheveled-associated activator of morphogenesis 1, transcript variant X3
disheveled-associated activator of morphogenesis 1 isoform X1
disheveled-associated activator of morphogenesis 1 isoform X3
disheveled-associated activator of morphogenesis 1 isoform X2
uncharacterized LOC125051639, transcript variant X2
uncharacterized LOC125051639, transcript variant X5
uncharacterized LOC125051639, transcript variant X1
uncharacterized LOC125051639, transcript variant X3
uncharacterized LOC125051639, transcript variant X4
uncharacterized protein LOC125051639 isoform X2
uncharacterized protein LOC125051639 isoform X1
uncharacterized LOC125051639, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 162 samples with support for all annotated introns
uncharacterized protein LOC125051639 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
probable tubulin polyglutamylase ttll-15
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 150 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit beta
26S proteasome non-ATPase regulatory subunit 1
signal recognition particle receptor subunit alpha homolog
alpha-(1,6)-fucosyltransferase, transcript variant X1
alpha-(1,6)-fucosyltransferase, transcript variant X2
neurogenic locus protein delta, transcript variant X1
neurogenic locus protein delta, transcript variant X2
neurogenic locus protein delta isoform X1
neurogenic locus protein delta isoform X2
fibroin heavy chain-like, transcript variant X1
fibroin heavy chain-like, transcript variant X2
tetra-peptide repeat homeobox protein 1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
shematrin-like protein 2, transcript variant X2
shematrin-like protein 2, transcript variant X1
keratin, type II cytoskeletal 3-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125051970, transcript variant X2
uncharacterized LOC125051970, transcript variant X3
uncharacterized LOC125051970, transcript variant X1
uncharacterized protein LOC125051970 isoform X2
uncharacterized protein LOC125051970 isoform X1
uncharacterized LOC125051970, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
uncharacterized LOC125051970, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
uncharacterized LOC125051970, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 57 samples with support for all annotated introns
uncharacterized LOC125051970, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
uncharacterized LOC125051970, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
uncharacterized LOC125051975, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 90 samples with support for all annotated introns
uncharacterized LOC125051975, transcript variant X2
uncharacterized LOC125051972, transcript variant X3
uncharacterized LOC125051972, transcript variant X1
uncharacterized LOC125051972, transcript variant X2
uncharacterized protein LOC125051972 isoform X3
uncharacterized protein LOC125051972 isoform X1
uncharacterized protein LOC125051972 isoform X2
uncharacterized LOC125052063, transcript variant X3
uncharacterized LOC125052063, transcript variant X1
uncharacterized protein LOC125052063 isoform X3
uncharacterized protein LOC125052063 isoform X1
uncharacterized LOC125052063, transcript variant X2
uncharacterized protein LOC125052063 isoform X2
uncharacterized LOC125051900, transcript variant X2
uncharacterized LOC125051900, transcript variant X1
uncharacterized protein LOC125051900 isoform X2
uncharacterized protein LOC125051900 isoform X1
aldehyde oxidase 1-like, transcript variant X2
aldehyde oxidase 1-like, transcript variant X1
xanthine dehydrogenase 1-like isoform X1
uncharacterized LOC125051680, transcript variant X2
uncharacterized LOC125051680, transcript variant X1
uncharacterized LOC125051680, transcript variant X3
uncharacterized LOC125051680, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC125051677, transcript variant X2
uncharacterized LOC125051677, transcript variant X1
uncharacterized protein LOC125051677 isoform X1
uncharacterized protein LOC125051677 isoform X2
uncharacterized LOC125051679, transcript variant X2
uncharacterized LOC125051679, transcript variant X1
uncharacterized protein LOC125051679 isoform X1
uncharacterized protein LOC125051679 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125051851, transcript variant X4
uncharacterized LOC125051851, transcript variant X1
uncharacterized LOC125051851, transcript variant X3
uncharacterized LOC125051851, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 113 samples with support for all annotated introns
cytochrome b5-like, transcript variant X2
cytochrome b5-like, transcript variant X1
cytochrome b5-like, transcript variant X3
cytochrome b5-like, transcript variant X4
cytochrome b5-like, transcript variant X6
nitrate reductase [NADPH]-like isoform X1
cytochrome b5-like, transcript variant X5
probable methyltransferase-like protein 25
ecdysteroid-regulated 16 kDa protein-like
uncharacterized LOC125051545, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 25 samples with support for all annotated introns
uncharacterized LOC125051545, transcript variant X3
uncharacterized LOC125051545, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 146 samples with support for all annotated introns
mitochondrial 2-oxodicarboxylate carrier
pecanex-like protein 1, transcript variant X1
pecanex-like protein 1, transcript variant X3
pecanex-like protein 1, transcript variant X2
pecanex-like protein 1, transcript variant X4
thioredoxin, mitochondrial, transcript variant X1
thioredoxin, mitochondrial, transcript variant X3
thioredoxin, mitochondrial, transcript variant X4
thioredoxin, mitochondrial, transcript variant X2
thioredoxin, mitochondrial, transcript variant X5
kinesin light chain, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 38 samples with support for all annotated introns
kinesin light chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
kinesin light chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
kinesin light chain, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
kinesin light chain, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
kinesin light chain, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 86 samples with support for all annotated introns
kinesin light chain, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
kinesin light chain, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
kinesin light chain, transcript variant X7
kinesin light chain, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 47 samples with support for all annotated introns
kinesin light chain, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
kinesin light chain, transcript variant X10
uncharacterized LOC125052031, transcript variant X4
uncharacterized LOC125052031, transcript variant X3
uncharacterized LOC125052031, transcript variant X1
uncharacterized LOC125052031, transcript variant X2
uncharacterized protein LOC125052031 isoform X3
uncharacterized protein LOC125052031 isoform X2
uncharacterized protein LOC125052031 isoform X1
probable 39S ribosomal protein L49, mitochondrial
breast cancer metastasis-suppressor 1-like protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 41 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 93 samples with support for all annotated introns
mitogen-activated protein kinase kinase kinase 11, transcript variant X1
mitogen-activated protein kinase kinase kinase 11, transcript variant X3
mitogen-activated protein kinase kinase kinase 11, transcript variant X2
mitogen-activated protein kinase kinase kinase 11, transcript variant X4
mitogen-activated protein kinase kinase kinase 11 isoform X1
mitogen-activated protein kinase kinase kinase 11 isoform X3
mitogen-activated protein kinase kinase kinase 11 isoform X2
mitogen-activated protein kinase kinase kinase 11 isoform X4
39S ribosomal protein L33, mitochondrial
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase, transcript variant X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase, transcript variant X2
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase, transcript variant X3
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase isoform X1
1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase isoform X2
chymotrypsin-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
zinc finger protein 62-like, transcript variant X3
zinc finger protein 62-like, transcript variant X2
zinc finger protein 62-like, transcript variant X1
chymotrypsin-1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125051544, transcript variant X2
uncharacterized LOC125051544, transcript variant X1
uncharacterized LOC125051544, transcript variant X3
uncharacterized protein LOC125051544 isoform X1
uncharacterized protein LOC125051544 isoform X2
dopamine D2-like receptor, transcript variant X1
dopamine D2-like receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transfer RNA proline (anticodon UGG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
xanthine dehydrogenase/oxidase-like, transcript variant X1
xanthine dehydrogenase/oxidase-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
xanthine dehydrogenase/oxidase-like isoform X1
altered inheritance of mitochondria protein 3-like
secretory phospholipase A2 receptor-like
40S ribosomal protein S12, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 66% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125051731, transcript variant X1
uncharacterized protein LOC125051731 isoform X1
uncharacterized LOC125051731, transcript variant X2
uncharacterized protein LOC125051731 isoform X2
E3 ubiquitin-protein ligase Arkadia-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
eukaryotic peptide chain release factor GTP-binding subunit-like
DNA-directed RNA polymerase II subunit rpb1-like
probable peroxisomal membrane protein PEX13
DNA repair protein XRCC1, transcript variant X1
DNA repair protein XRCC1, transcript variant X2
eukaryotic translation initiation factor 3 subunit F
ribosome biogenesis protein BOP1 homolog
rho GTPase-activating protein 4-like, transcript variant X1
rho GTPase-activating protein 4-like, transcript variant X2
rho GTPase-activating protein 4-like, transcript variant X4
rho GTPase-activating protein 4-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
rho GTPase-activating protein 4-like isoform X1
rho GTPase-activating protein 4-like isoform X2
rho GTPase-activating protein 4-like isoform X4
rho GTPase-activating protein 4-like isoform X5
rho GTPase-activating protein 4-like, transcript variant X3
rho GTPase-activating protein 4-like isoform X3
regulator of G-protein signaling 19, transcript variant X1
regulator of G-protein signaling 19, transcript variant X2
regulator of G-protein signaling 19 isoform X1
regulator of G-protein signaling 19 isoform X2